Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Squirrel AI: Learning by Scaling
Ciesinski, Stephen; Conn, JeffreyCaso SGSB-E-666-EIniciativa emprendedoraThis case provides an overview of the founding and scaling of Chinese artificial intelligence-enabled adaptive learning company Squirrel AI. The case details founder Derek Haoyang Li’s struggles to build and scale a comprehensive cutting-edge product and accompanying business model for China’s large and growing after-school education industry.Desde 8,20 €
-
Mines (A): Searching for the Right Nail
Reiss, Peter; Conn, JeffreyCaso SGSB-E-661-EIniciativa emprendedoraThis case examines the founding story of machine learning-enabled lending platform Mines and CEO Ekechi Nwokah. The case focuses on Nwokah’s exploration and initial analysis of the different potential verticals and geographies his team could target to solve business problems using its proprietary cloud-based data platform. Students will be confronted with numerous entrepreneurial issues including founder partnership, fundraising, initial industr...Desde 8,20 €
-
23andMe: A Virtuous Loop
Siegel, Robert; Conn, JeffreyCaso SGSB-E688-EIniciativa emprendedoraThis case describes 23andMe CEO and cofounder Anne Wojcicki’s founding story and her recent attempts to scale the company’s direct-to-consumer genetic testing franchise while simultaneously expanding its pharmaceutical development aspirations.Desde 8,20 €
-
Clinova: Diagnose and Decide
Foster, George; Conn, JeffreyCaso SGSB-E699-EIniciativa emprendedoraThis case provides an overview of the founding and scaling story of British health and wellness company Clinova. The case outlines the fledgling company’s early marketing successes signing up-and-coming athletes and sports franchises, as well as the difficult capital allocation, strategic and structural decisions Clinova’s founders Arsalan Karim and Charles Ebubedike must make between scaling their consumer product lines or building their illness...Desde 8,20 €